PMID: 9545995Apr 18, 1998Paper

Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a randomized double-blind study. The Risperidone Study Group

The American Journal of Psychiatry
G BondolfiP Baumann

Abstract

The purpose of this study was to compare the short-term efficacy and safety of risperidone and clozapine in treatment-resistant chronic schizophrenic patients. In a controlled double-blind, multicenter study, 86 inpatients with chronic schizophrenia (DSM-III-R), who were resistant to or intolerant of conventional neuroleptics, were randomly assigned to receive risperidone or clozapine for 8 weeks after a 7-day washout period. After a 1-week dose-titration phase, doses were fixed at 6 mg/day of risperidone and 300 mg/day of clozapine for 1 week and then adjusted according to each patient's response. The final mean doses were 6.4 mg/day of risperidone and 291.2 mg/day of clozapine. Treatment efficacy and safety were evaluated with several well-known rating scales. Both risperidone and clozapine significantly reduced the severity of psychotic symptoms (scores on the Positive and Negative Syndrome Scale and the Clinical Global Impression scale) from baseline, with no significant between-group differences. At endpoint, 67% of the risperidone group and 65% of the clozapine group were clinically improved (reduction of 20% or more in total Positive and Negative Syndrome Scale score). Risperidone appeared to have a faster onset of actio...Continue Reading

Citations

Dec 22, 2011·The British Journal of Psychiatry : the Journal of Mental Science·Takefumi SuzukiDavid C Mamo
Dec 21, 2000·Current Psychiatry Reports·D C Javitt
Dec 21, 2000·Current Psychiatry Reports·R M Steel, E C Johnstone
Jan 5, 2001·European Child & Adolescent Psychiatry·H RemschmidtE Schulz
Nov 4, 2006·Der Nervenarzt·W W Fleischhacker, W Hummer
Apr 6, 2004·Schizophrenia Research·Peter F BuckleyRobin A Emsley
Dec 31, 2002·Psychoneuroendocrinology·R Tandon, M D Jibson
Jan 1, 1999·International Journal of Psychiatry in Clinical Practice·D Lecompte, R F Cookson
Jan 1, 1999·International Journal of Psychiatry in Clinical Practice·M V CheineM Rimón
Jan 1, 2002·Expert Review of Neurotherapeutics·Leslie Citrome, Jan Volavka
May 1, 2003·Expert Review of Neurotherapeutics·Jambur AnanthSarath Gunatilake
Jul 5, 2005·Expert Opinion on Investigational Drugs·N A Keks, C Culhane
Mar 16, 2001·Expert Opinion on Pharmacotherapy·R C Love, M W Nelson
Jul 14, 2000·Current Medical Research and Opinion·B Green
Feb 24, 2001·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·T Wetterling
Jun 20, 2003·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Hubert H FernandezJoseph H Friedman
Jul 28, 2012·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Alkomiet HasanUNKNOWN World Federation of Societies of Biological Psychiatry (WFSBP) Task Force on Treatment Guidelines for Schizophrenia
Feb 28, 2003·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·N GhaemiF K Goodwin
Sep 22, 2005·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Peter FalkaiUNKNOWN WFSBP Task Force on Treatment Guidelines for Schizophrenia
Jan 20, 2016·Journal of Child and Adolescent Psychopharmacology·Lauren I KasoffJudith L Rapoport
Jul 17, 2009·Schizophrenia Research·Emilio SacchettiUNKNOWN MOZART Study Group
Mar 10, 2009·Schizophrenia Research·Emilio SacchettiUNKNOWN INITIATE Study Group
Dec 3, 2005·Child and Adolescent Psychiatric Clinics of North America·Harvey N KranzlerSanjiv Kumra
May 24, 2007·Journal of Evaluation in Clinical Practice·Mark Bounthavong, Mark P Okamoto
Dec 18, 2001·Biological Psychiatry·R R Conley, D L Kelly
May 25, 2016·The Psychiatric Clinics of North America·Helio Elkis, Peter F Buckley
Oct 11, 2005·Neurobiology of Learning and Memory·Mark E BardgettShannon M O'Connell
Apr 10, 2003·The Psychiatric Clinics of North America·Robin Emsley, Piet Oosthuizen
Dec 1, 1999·Biological Psychiatry·J M Kane
Aug 27, 2014·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Jimmy LeeGary Remington
Nov 1, 2001·Expert Review of Neurotherapeutics·J A HormaecheaJ C Gómez
May 4, 2004·Current Medical Research and Opinion·Stephen Layton, Martin Barbeau
Mar 16, 2001·Expert Opinion on Pharmacotherapy·B C Lund, P J Perry
Jun 7, 2005·Expert Opinion on Pharmacotherapy·Hans-Jürgen Möller
Jan 24, 2007·BMC Psychiatry·Thomas J RaedlerKlaus Wiedemann
May 23, 2015·European Journal of Psychotraumatology·Ulrike Schmidt
Oct 18, 2011·Schizophrenia Research·Takefumi SuzukiDavid C Mamo
Jun 1, 2013·Schizophrenia Research·André ZugmanAndrea P Jackowski

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here